Log in using OpenID

Next Generation Sequencing Market Benefit and Volume 2017 with Status and Prospect

The global next generation sequencing market was valued at US$ 5.6 billion in 2017 and is expected to witness a robust CAGR of 18.1% By 2025.
Next Generation Sequencing Market Size,
Share, Trend, Outlook, Future Growth
Analysis And Synthesis 2017 - 2025
Next Generation Sequencing (NGS) is a powerful, flexible, and indispensable biological tool that is used
in several areas of biological study. NGS technologies help in generating genome-wide sequence data in
a couple of days. These technologies are highly parallelized allowing to sequence thousands to millions
of molecules at the same time. The main advantage of these platforms is determination of the sequenced
data from amplified single DNA fragments, avoiding the need for cloning of DNA fragments.
NGS has large number of applications, enabling rapid technological advances across several fields in
biological science. The technology has enabled researchers to gain significant knowledge in public health
studies and epidemiology, to sequence viruses and bacteria and help detect causes that may contribute
to virulence. Furthermore, in gene expression research, next generation sequencing of RNA replace
microarray analysis, allowing researchers to see RNA expression sequence. This RNA sequencing can
provide information on entire transcriptome in one analysis, irrespective of any previous knowledge of
genetic sequence.
Free Request Sample of Report:
The global next generation sequencing market was valued at US$ 5.6 billion in 2017 and is expected to
witness a robust CAGR of 18.1% over the forecast period (2017–2025).
Rising demand for early detection of cancer and infectious diseases to drive growth of the NGS market
The chances of successful treatment increase when cancer and infectious diseases are detected at the
early stage. One of the major factors that drive growth of the next generation sequencing market is the
rising prevalence of cancer and other infectious diseases. According to the World Health Organization
(WHO), in 2012, new cases of cancer was around 14 million and the incidence is estimated to increase
to 70% by 2030.
Increasing demand for DNA testing
Demand for DNA testing is increasing, due to advancements in whole genome and exome sequencing
procedures, faster results and cost effectives of the process as compared to genotyping based DNA
microarray. In December, 2014, the first commercial sequencer, MinIon, using Nanopore technology was
introduced by Oxford Nanopore Technologies. The sequencer identifies DNA by measuring the changes in
the electrical conductivity generated DNA strands passed through biological pore. This technology
enabled the detection of outbreaks such as Zika virus. Furthermore, GenapSys, a U.S.-based developer of
DNA sequencing technologies for applied genomic testing, introduced GENIUS sequencer, which can
sequence DNA anywhere.
Report includes chapters which deeply display the following deliverable about industry :
• Next Generation Sequencing Market Research Objective and Assumption
• Next Generation Sequencing Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Next Generation Sequencing Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Next Generation Sequencing Market, By Regions
• Next Generation Sequencing Market Competition by Manufacturers including Production,
Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Next Generation Sequencing Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Next Generation Sequencing Market Manufacturing Cost Analysis including Key Raw Materials
and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Next Generation Sequencing Market Forecast including Production, Consumption, Import and
Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Next Generation Sequencing Market - Competitor Analysis
Key players in the next generation sequencing market include Thermo Fisher Scientific Inc., Agilent
Technologies, Inc., BioMerieux S.A., F. Hoffmann-La Roche Ltd, Qiagen N.V., Illumina, Inc., Oxford
Nanopore Technologies, and Beijing Genomics Co. Ltd.
Detailed Segmentation:
Global Next Generation Sequencing Market, By Technology:
Whole Genome Sequencing
Whole Exome Sequencing
RNA Sequencing
Targeted Re-sequencing
Global Next Generation Sequencing Market, By Application:
Drug Discovery
Personalized Medicine and Genetic Screening
Disease Diagnosis
Agriculture and Animal Research
Browse Research Report @
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Poul Master
Poul Master247   documents Email
Health and Medicine
File Size
120 KB
market, Next Generation Sequencing Market
Report inappropriate content